Priority scheduling with direct physician access Comprehensive annual longevity assessment Custom regenerative therapy protocols Quarterly biomarker optimization panels Telehealth between in-person visits
How the 1999 Ghrelin Discovery Reframed the Target A conceptual shift arrived in December 1999, when Kojima and colleagues at Kurume University identified ghrelin, a 28-amino-acid acylated peptide predominantly produced by gastric X/A-like cells, as the endogenous ligand for GHS-R1a
MT-II (Melanotan II) is studied for melanogenesis and skin tanning via MC1R activation on melanocytes
No, Phentermine is not an amphetamine
DSIP crosses the blood-brain barrier freely an unusual property for a peptide of its size via a non-competitive, non-saturable passive mechanism whose physicochemical determinants (lipophilicity, charge, molecular weight, and protein-binding) are now well characterised